Skip to content
← Full study record

NCT03875495 · OUTCOME

Changes in Quality of Life: European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM) · Source last updated 2022-01-28

This outcome was registered, but no numerical results were posted in the captured record.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
2 years

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denom Units Selected
Participants
reporting Status
NOT_POSTED
time Frame
2 years
title
Changes in Quality of Life: European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice